Fri, Jul 28, 2023
Dr Reddy's Laboratories (DRL) shares have scaled a series of record peaks in the past few days. This week, the pharmaceutical major reported a strong all-round quarterly performance, with a better-than-expected 18.2 per cent year-on-year increase in net profit to Rs 1,405 crore for the April-June period.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
